291 related articles for article (PubMed ID: 9708225)
21. Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women.
Diamond T; McGuigan L; Barbagallo S; Bryant C
Am J Med; 1995 May; 98(5):459-63. PubMed ID: 7733124
[TBL] [Abstract][Full Text] [Related]
22. A pooled data analysis on the use of intermittent cyclical etidronate therapy for the prevention and treatment of corticosteroid induced bone loss.
Adachi JD; Roux C; Pitt PI; Cooper C; Moniz C; Dequeker J; Ioannidis G; Cawley MI; Jenkins EA; Walker-Bone KE; Pack S; Stephenson GF; Laan RF; Brown J; Geusens P
J Rheumatol; 2000 Oct; 27(10):2424-31. PubMed ID: 11036840
[TBL] [Abstract][Full Text] [Related]
23. Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy.
Wallach S; Cohen S; Reid DM; Hughes RA; Hosking DJ; Laan RF; Doherty SM; Maricic M; Rosen C; Brown J; Barton I; Chines AA
Calcif Tissue Int; 2000 Oct; 67(4):277-85. PubMed ID: 11000340
[TBL] [Abstract][Full Text] [Related]
24. Cyclical etidronate increases lumbar spine bone density in patients on long-term glucocorticosteroid therapy.
Skingle SJ; Moore DJ; Crisp AJ
Int J Clin Pract; 1997 Sep; 51(6):364-7. PubMed ID: 9489064
[TBL] [Abstract][Full Text] [Related]
25. A four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis.
Wimalawansa SJ
Am J Med; 1998 Mar; 104(3):219-26. PubMed ID: 9552083
[TBL] [Abstract][Full Text] [Related]
26. Effects of cyclical etidronate with alfacalcidol on lumbar bone mineral density, bone resorption, and back pain in postmenopausal women with osteoporosis.
Iwamoto J; Takeda T; Ichimura S; Matsu K; Uzawa M
J Orthop Sci; 2003; 8(4):532-7. PubMed ID: 12898306
[TBL] [Abstract][Full Text] [Related]
27. The prevention of corticosteroid-induced bone loss with intermittent cyclical etidronate.
Jenkins EA; Walker-Bone KE; Wood A; McCrae FC; Cooper C; Cawley MI
Scand J Rheumatol; 1999; 28(3):152-6. PubMed ID: 10380836
[TBL] [Abstract][Full Text] [Related]
28. 36 month intermittent cyclical etidronate treatment in patients with established corticosteroid induced osteoporosis.
Sebaldt RJ; Ioannidis G; Adachi JD; Bensen WG; Bianchi F; Cividino A; Gordon M; Kaminska E; Scocchia T; Petrie A; Stephenson GF; Goldsmith CH
J Rheumatol; 1999 Jul; 26(7):1545-9. PubMed ID: 10405943
[TBL] [Abstract][Full Text] [Related]
29. Comparison of changes in bone mineral in idiopathic and secondary osteoporosis following therapy with cyclical disodium etidronate and high dose calcium supplementation.
Orme SM; Simpson M; Stewart SP; Oldroyd B; Westmacott CF; Smith MA; Belchetz PE
Clin Endocrinol (Oxf); 1994 Aug; 41(2):245-50. PubMed ID: 7923830
[TBL] [Abstract][Full Text] [Related]
30. Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study.
Wolfhagen FH; van Buuren HR; den Ouden JW; Hop WC; van Leeuwen JP; Schalm SW; Pols HA
J Hepatol; 1997 Feb; 26(2):325-30. PubMed ID: 9059953
[TBL] [Abstract][Full Text] [Related]
31. Effect of intermittent cyclical disodium etidronate therapy on bone mineral density in men with vertebral fractures.
Anderson FH; Francis RM; Bishop JC; Rawlings DJ
Age Ageing; 1997 Sep; 26(5):359-65. PubMed ID: 9351480
[TBL] [Abstract][Full Text] [Related]
32. Clinical effect of bisphosphonate and vitamin D on osteoporosis: reappraisal of a multicenter double-blind clinical trial comparing etidronate and alfacalcidol.
Fujita T; Orimo H; Inoue T; Kaneda K; Sakurai M; Morita R; Yamamoto K; Sugioka Y; Inoue A; Takaoka K; Yamamoto I; Hoshino Y; Kawaguchi H
J Bone Miner Metab; 2007; 25(2):130-7. PubMed ID: 17323183
[TBL] [Abstract][Full Text] [Related]
33. Longterm effect of intermittent cyclical etidronate therapy on corticosteroid-induced osteoporosis in Japanese patients with connective tissue disease: 7-year followup.
Sato S; Takada T; Katsuki Y; Kimura N; Kaneko Y; Suwa A; Hirakata M; Kuwana M
J Rheumatol; 2008 Jan; 35(1):142-6. PubMed ID: 18050368
[TBL] [Abstract][Full Text] [Related]
34. Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy.
Reid DM; Adami S; Devogelaer JP; Chines AA
Calcif Tissue Int; 2001 Oct; 69(4):242-7. PubMed ID: 11730260
[TBL] [Abstract][Full Text] [Related]
35. Effects of cyclical etidronate combined with calcitriol versus cyclical etidronate alone on spine and femoral neck bone mineral density in postmenopausal osteoporotic women.
Masud T; Mulcahy B; Thompson AV; Donnelly S; Keen RW; Doyle DV; Spector TD
Ann Rheum Dis; 1998 Jun; 57(6):346-9. PubMed ID: 9771208
[TBL] [Abstract][Full Text] [Related]
36. The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy.
Diamond T; Campbell J; Bryant C; Lynch W
Cancer; 1998 Oct; 83(8):1561-6. PubMed ID: 9781950
[TBL] [Abstract][Full Text] [Related]
37. Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss.
Adachi J; Cranney A; Goldsmith CH; Bensen WG; Bianchi F; Cividino A; Craig GL; Kaminska E; Sebaldt RJ; Papaioannou A
J Rheumatol; 1994 Oct; 21(10):1922-6. PubMed ID: 7837160
[TBL] [Abstract][Full Text] [Related]
38. Prevention of glucocorticoid-induced osteoporosis in immunobullous diseases with alendronate: a randomized, double-blind, placebo-controlled study.
Tee SI; Yosipovitch G; Chan YC; Chua SH; Koh ET; Chan YH; Tan SS; Tsou IY; Tan SH
Arch Dermatol; 2012 Mar; 148(3):307-14. PubMed ID: 22105813
[TBL] [Abstract][Full Text] [Related]
39. Are oral bisphosphonates effective in improving lumbar bone mineral density in breast cancer survivors with osteopenia or osteoporosis?
Sawka AM; Ioannidis G; Papaioannou A; Thabane L; Olszynski WP; Brown JP; Hanley DA; Murray TM; Josse RG; Sebaldt RJ; Petrie A; Tenenhouse A; Goldsmith CH; Boulos P; Kouroukis T; Adachi JD
J Obstet Gynaecol Can; 2005 Aug; 27(8):759-64. PubMed ID: 16287007
[TBL] [Abstract][Full Text] [Related]
40. Positive effect of etidronate therapy is maintained after drug is terminated in patients using corticosteroids.
Brown JP; Olszynski WP; Hodsman A; Bensen WG; Tenenhouse A; Anastassiades TP; Ste-Marie LG; Kendler DL; Hanley DA; Josse R; Hanly JG; Lentle B; Jovaisas A; Ioannidis G; Stephenson GF; Barton I; Pack S; Chines A; Dias R; Adachi JD
J Clin Densitom; 2001; 4(4):363-71. PubMed ID: 11748341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
